UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

The Lancet (British edition), 2011-07, Vol.378 (9787), p.238-246

2011

Volltextzugriff (PDF)

Exploring the impact of HIV infection and antiretroviral therapy on placenta morphology

Placenta (Eastbourne), 2021-01, Vol.104, p.102-109

2021

Volltextzugriff (PDF)

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

The Lancet (British edition), 2006-08, Vol.368 (9534), p.466-475

2006

Volltextzugriff (PDF)

HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine

Vaccine, 2016-09, Vol.34 (40), p.4799-4806

2016

Volltextzugriff (PDF)

Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis

Drug and alcohol dependence, 2018-04, Vol.185, p.374-380

2018

Volltextzugriff (PDF)

Management of Persons Infected with Human Immunodeficiency Virus Requiring Admission to the Intensive Care Unit

Critical care clinics, 2013-07, Vol.29 (3), p.603-620

2013

Volltextzugriff (PDF)

Response to Stegmann S, et al. [J. Clin. Virol. 47 (1) (2010) 79–81]

Journal of clinical virology, 2010-03, Vol.47 (3), p.297-298

2010

Volltextzugriff (PDF)

Plea for multitargeted interventions for severe COVID-19

The Lancet infectious diseases, 2020-10, Vol.20 (10), p.1122-1123

2020

Volltextzugriff (PDF)

Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada

The International journal of drug policy, 2022-05, Vol.103, p.103627-103627, Article 103627

2022

Volltextzugriff (PDF)

The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination

The International journal of drug policy, 2023-04, Vol.114, p.103981-103981, Article 103981

2023

Volltextzugriff (PDF)

Low human papillomavirus (HPV) vaccine uptake among men living with human immunodeficiency virus (HIV): Cross-sectional findings from a clinical cohort

Preventive medicine, 2021-02, Vol.143, p.106329-106329, Article 106329

2021

Volltextzugriff (PDF)

Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination

International journal of gynecology and obstetrics, 2020-07, Vol.150 (1), p.108-115

2020

Volltextzugriff (PDF)

Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV

Vaccine, 2020-03, Vol.38 (15), p.3073-3078

2020

Volltextzugriff (PDF)

Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals

The International journal of drug policy, 2019-03, Vol.65, p.41-49

2019

Volltextzugriff (PDF)

Comparison of hemagglutination inhibition and microbead array assays for the measurement of influenza antibody levels in HIV-infected adults

Vaccine, 2016-06, Vol.34 (31), p.3584-3591

2016

Volltextzugriff (PDF)

Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003–2011

Vaccine, 2016-02, Vol.34 (6), p.846-853

2016

Volltextzugriff (PDF)

Canadian HIV Pregnancy Planning Guidelines: No. 278, June 2012

International journal of gynecology and obstetrics, 2012-10, Vol.119 (1), p.89-99

2012

Volltextzugriff (PDF)

Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions

Journal of clinical virology, 2013-12, Vol.58 (4), p.660-665

2013

Volltextzugriff (PDF)

Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV

Journal of clinical virology, 2008-11, Vol.43 (3), p.307-312

2008

Volltextzugriff (PDF)

Design and methods of the MAINTAIN study: A randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection

Contemporary clinical trials, 2010-11, Vol.31 (6), p.604-611

2010

Volltextzugriff (PDF)

Codevelopment of new antiretrovirals in very treatment-experienced HIV-infected individuals

The Lancet (British edition), 2004-09, Vol.364 (9439), p.1036-1037

2004

Volltextzugriff (PDF)

Reproducibility of DXA estimations of body fat in HIV lipodystrophy: implications for clinical research

Journal of clinical densitometry, 2005, Vol.8 (3), p.293-297

2005

Volltextzugriff (PDF)

CTN-194 (PICCO): Design of a trial of citalopram for the prevention of depression and its consequences in HIV-Hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy

Contemporary clinical trials, 2008-07, Vol.29 (4), p.617-630

2008

Volltextzugriff (PDF)

Reproducibility of DXA Estimations of Body Fat in HIV Lipodystrophy

Journal of clinical densitometry, 2005-09, Vol.8 (3), p.293-297

2005

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionScienceDirect Journals (5 years ago - present)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mpox in people with past infection or a complete vaccination course: a global case series

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

Exploring the impact of HIV infection and antiretroviral therapy on placenta morphology

HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine

Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis

Management of Persons Infected with Human Immunodeficiency Virus Requiring Admission to the Intensive Care Unit

Response to Stegmann S, et al. [J. Clin. Virol. 47 (1) (2010) 79–81]

Plea for multitargeted interventions for severe COVID-19

Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada

The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination

Low human papillomavirus (HPV) vaccine uptake among men living with human immunodeficiency virus (HIV): Cross-sectional findings from a clinical cohort

Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination

Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV

Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals

Comparison of hemagglutination inhibition and microbead array assays for the measurement of influenza antibody levels in HIV-infected adults

Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003–2011

Canadian HIV Pregnancy Planning Guidelines: No. 278, June 2012

Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions

Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV

Design and methods of the MAINTAIN study: A randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection

Codevelopment of new antiretrovirals in very treatment-experienced HIV-infected individuals

Reproducibility of DXA estimations of body fat in HIV lipodystrophy: implications for clinical research

CTN-194 (PICCO): Design of a trial of citalopram for the prevention of depression and its consequences in HIV-Hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy

Reproducibility of DXA Estimations of Body Fat in HIV Lipodystrophy

Aktive Filter

Suchergebnisse filtern